Intramuscular Delivery of scAAV9-hIGF1 Prolongs Survival in the hSOD1G93A ALS Mouse Model via Upregulation of D-Amino Acid Oxidase (Q40416649)

20 September 2017

Intramuscular Delivery of scAAV9-hIGF1 Prolongs Survival in the hSOD1G93A ALS Mouse Model via Upregulation of D-Amino Acid Oxidase (English)

1 reference

amyotrophic lateral sclerosis

20 September 2017

1 reference

HuiQian Lin

1

1 reference

20 September 2017

HaoJie Hu

2

1 reference

20 September 2017

WeiSong Duan

3

1 reference

20 September 2017

YaLing Liu

4

1 reference

20 September 2017

GuoJun Tan

5

1 reference

20 September 2017

ZhongYao Li

6

1 reference

20 September 2017

YaKun Liu

7

1 reference

20 September 2017

BinBin Deng

8

1 reference

20 September 2017

XueQin Song

9

1 reference

20 September 2017

Wan Wang

10

1 reference

20 September 2017

Di Wen

11

1 reference

20 September 2017

Ying Wang

12

1 reference

20 September 2017

ChunYan Li

13

1 reference

20 September 2017

19 December 2016

1 reference

20 September 2017

Molecular Neurobiology

1 reference

https://scigraph.springernature.com/pub.10.1007/s12035-016-0335-z

20 September 2017

0 references

cites work

Amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0335-Z

Amyotrophic Lateral Sclerosis and the Military: A Population-based Study in the Danish Registries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0335-Z

Unraveling the mechanisms involved in motor neuron degeneration in ALS

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0335-Z

D-serine is a key determinant of glutamate toxicity in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0335-Z

D-amino acid oxidase controls motoneuron degeneration through D-serine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0335-Z

Activity of D-amino acid oxidase is widespread in the human central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0335-Z

The role of D-serine and glycine as co-agonists of NMDA receptors in motor neuron degeneration and amyotrophic lateral sclerosis (ALS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0335-Z

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0335-Z

Subcutaneous IGF-1 is not beneficial in 2-year ALS trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0335-Z

Lentivector-mediated SMN replacement in a mouse model of spinal muscular atrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0335-Z

Neuroprotection of spinal motoneurons following targeted transduction with an adenoviral vector carrying the gene for glial cell line-derived neurotrophic factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0335-Z

Intramuscular injection of AAV8 in mice and macaques is associated with substantial hepatic targeting and transgene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0335-Z

Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0335-Z

AAV4-mediated expression of IGF-1 and VEGF within cellular components of the ventricular system improves survival outcome in familial ALS mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0335-Z

Delivery of AAV-IGF-1 to the CNS extends survival in ALS mice through modification of aberrant glial cell activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0335-Z

Efficient Retrograde Neuronal Transduction Utilizing Self-complementary AAV1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0335-Z

Intravenous administration of self-complementary AAV9 enables transgene delivery to adult motor neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0335-Z

Efficient transduction of non-human primate motor neurons after intramuscular delivery of recombinant AAV serotype 6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0335-Z

Guidelines for preclinical animal research in ALS/MND: A consensus meeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0335-Z

Spinal muscular atrophy and the antiapoptotic role of survival of motor neuron (SMN) protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0335-Z

Significance of behavioural tests in a transgenic mouse model of amyotrophic lateral sclerosis (ALS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0335-Z

Update on the glutamatergic neurotransmitter system and the role of excitotoxicity in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0335-Z

The advent of AAV9 expands applications for brain and spinal cord gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0335-Z

Self-complementary recombinant adeno-associated virus (scAAV) vectors promote efficient transduction independently of DNA synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0335-Z

Pathogenic effects of amyotrophic lateral sclerosis-linked mutation in D-amino acid oxidase are mediated by D-serine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0335-Z

Familial amyotrophic lateral sclerosis is associated with a mutation in D-amino acid oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0335-Z

Methods to evaluate functional nerve recovery in adult rats: walking track analysis, video analysis and the withdrawal reflex

21 January 2018

1 reference

12 December 2020

Effect of transgene copy number on survival in the G93A SOD1 transgenic mouse model of ALS

1 reference

12 December 2020

A Single Injection of Recombinant Adeno-Associated Virus into the Lumbar Cistern Delivers Transgene Expression Throughout the Whole Spinal Cord.

1 reference

12 December 2020

Functional Role of Caspase-1 and Caspase-3 in an ALS Transgenic Mouse Model

1 reference

12 December 2020

Mutant SOD1 mediated pathogenesis of Amyotrophic Lateral Sclerosis

1 reference

12 December 2020

A placebo-controlled trial of insulin-like growth factor-I in amyotrophic lateral sclerosis. European ALS/IGF-I Study Group

1 reference

12 December 2020

Recombinant human insulin-like growth factor-I in ALS: description of a double-blind, placebo-controlled study. North American ALS/IGF-I Study Group

1 reference

12 December 2020

Effect of recombinant human insulin-like growth factor-I on progression of ALS. A placebo-controlled study. The North America ALS/IGF-I Study Group

1 reference

12 December 2020

10.1007/S12035-016-0335-Z

Identifiers

DOI

0 references

Dimensions Publication ID

0 references

1 reference